<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd">
<head>
<meta http-equiv="default-style" content="text/html; charset=utf-8" />
<title>Campbell-Walsh-Wein Urology Twelfth Edition Review</title>
<link rel="stylesheet" type="text/css" href="../../style/Elsevier_eBook.css" />
<link rel="stylesheet" type="text/css" media="only screen" href="../../style/media.css" />
  

<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/common.css" />
<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/variables.css" />
<script type="text/javascript" src="../../widgets/common_assets/scripts/mathjax/tex-mml-chtml.js"></script>
<script type="text/javascript" src="../../widgets/common_assets/scripts/common.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_data.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_parent.js"></script>

</head>
<body>
<section epub:type="chapter">
<a id="c0112"></a>
<header>
<div id="CN">112</div>
<h1 class="chaptitle" epub:type="title" id="B9780323639699001129">Evaluation and Management of Women With Urinary Incontinence and Pelvic Prolapse</h1>
<address>
<div class="chapau" id="augrp0010">Alvaro Lucioni, and Kathleen C. Kobashi</div>
</address>
</header>
<section>
<h3 class="h2hd" id="cesectitle0010">Keywords</h3>
<div class="keywords">cystoscopy; pelvic floors disorders; pelvic organ prolapse; POP-Q; urinary incontinence; urodynamics</div>
</section><span id="pagebreak_432"></span><span id="pagebreak_433"></span><span id="pagebreak_434"></span>
<iframe src="../../widgets/MCMS/xhtml/ch112_assessments.xhtml" height="700"></iframe>




<div class="boxg1" id="b0010">
<p></p>
<div class="b1title" epub:type="title" id="title5050">Chapter Review</div>
<div id="bpar0010"></div>
<div>
<ul class="ce_list" id="olist0095">
<li class="b1numlist" id="bpar0015">
<a id="o0535"></a>1. Pelvic floor disorders (PFDs) are a prevalent worldwide health concern.</li>
<li class="b1numlist" id="bpar0020">
<a id="o0540"></a>2. Careful history and physical with objective demonstration of incontinence are integral in the proper evaluation of patients with PFDs.</li>
<li class="b1numlist" id="bpar0025">
<a id="o0545"></a>3. Supplementary evaluation including urinalysis, postvoid residual, urodynamics, endoscopy, and radiologic imaging can be helpful in facilitating a complete and accurate diagnosis.</li>
<li class="b1numlist" id="bpar0030">
<a id="o0550"></a>4. A variety of surgical and nonsurgical treatment options are available for treatment of urinary incontinence and pelvic organ prolapse.</li>
<li class="b1numlist" id="bpar0035">
<a id="o0555"></a>5. The severity of PFD symptoms should be taken into account when considering treatment.</li>
<li class="b1numlist" id="bpar0040">
<a id="o0560"></a>6. A thorough history is essential in the diagnostic evaluation of patients with PFDs.</li>
<li class="b1numlist" id="bpar0045">
<a id="o0565"></a>7. Queries specific to the character, severity, duration, and quantity of incontinence and other symptoms related to pelvic floor function should be performed.</li>
<li class="b1numlist" id="bpar0050">
<a id="o0570"></a>8. Attention should be paid to the impact of PFD symptoms on quality of life (QoL).</li>
<li class="b1numlist" id="bpar0055">
<a id="o0575"></a>9. When appropriate, the clinician should present questions specific to the female with potential pelvic organ prolapse and the male with potential prostate issues.</li>
<li class="b1numlista" id="bpar0060">
<a id="o0580"></a>10. Queries regarding past medical and surgical history, obstetric and gynecologic history, radiation therapy, trauma, and medications may provide important information.</li>
<li class="b1numlista" id="bpar0065">
<a id="o0585"></a>11. A properly performed physical examination is imperative in the evaluation of patients with PFDs.</li>
<li class="b1numlista" id="bpar0070">
<a id="o0590"></a>12. The Centers for Medicare/Medicaid require specific elements of both male and female genitourinary examination in order to meet coding guidelines (see Table 112.4).</li>
<li class="b1numlista" id="bpar0075">
<a id="o0595"></a>13. Assessment of pelvic organ prolapse (POP) should ideally be performed in both the supine and standing positions.</li>
<li class="b1numlista" id="bpar0080">
<a id="o0600"></a>14. Several classification and quantification systems are available for assessment of POP, the most widely used of which (Baden-Walker and POP-Q) are illustrated in <a class="lightboxcallout" img-ref="image_fig_112_1" href="#f0010">Figs. 112.1</a> and <a class="lightboxcallout" img-ref="image_fig_112_2" href="#f0015">112.2</a>.</li>
<li class="b1numlista" id="bpar0085">
<a id="o0605"></a>15. A neurological examination and rectal examination should be performed in appropriate patients in order to obtain complete clinical information important in the assessment of lower urinary tract and pelvic floor function.</li>
<li class="b1numlista" id="bpar0090">
<a id="o0610"></a>16. It has been demonstrated that patient subjective history alone often does not reflect an accurate or complete picture of their symptomatology complex.</li>
<li class="b1numlista" id="bpar0095">
<a id="o0615"></a>17. Several instruments designed to facilitate symptom quantification have been developed and include tools such as voiding diaries, symptom and QoL questionnaires, and pad tests.</li>
<li class="b1numlista" id="bpar0100">
<a id="o0620"></a>18. Voiding diaries can be both diagnostic and therapeutic, as they can provide patients with insights into behaviors that may be contributing to their voiding symptoms.</li>
<li class="b1numlista" id="bpar0105">
<a id="o0625"></a>19. Pad tests may be helpful, particularly in the academic setting, to quantify incontinence symptoms. Loss of up to 8 g of urine in 24 hours may be considered normal, although the International Consultation on Incontinence (ICI) considers loss of greater than 1.3 g to be a positive 24-hour test.</li>
<li class="b1numlista" id="bpar0110">
<a id="o0630"></a>20. Validated questionnaires are available to assess symptoms and quality of life in patients with PFDs.</li>
<li class="b1numlista" id="bpar0115">
<a id="o0635"></a>21. Urodynamics (UDS) is the most accurate tool available for the assessment of LUT function and provides information regarding urine storage and emptying as they are affected by the bladder and the bladder outlet.</li>
<li class="b1numlista" id="bpar0120">
<a id="o0640"></a>22. Although the use of routine UDS for straightforward incontinence is a topic of discussion, UDS should be strongly considered prior to intervention in patients who have a complex clinical picture due to failed previous treatment or surgery, mixed incontinence, obstructive symptoms, significantly elevated PVR, neurologic disease, or other medical conditions that may contribute to the LUT function, such as diabetes mellitus, pelvic prolapse, or history of radiation therapy.</li>
<li class="b1numlista" id="bpar0125">
<a id="o0645"></a>23. “Eyeball UDS” may provide an approximate picture of the bladder capacity, sensation, stability, compliance, and outlet resistance when formal UDS is not available.<a id="pg435"></a>
</li>
<li id="sf0012">
<div class="pageavoid">
<figure class="fig" id="f0013">
<img src="../../IMAGES/B9780323639699001129/main.assets/f112-01-9780323639699.jpg" alt="image" class="box_img" />
<figcaption class="figleg">
<a id="cap0011"></a>
<a id="sp4565"></a>
<span class="fignum">Fig. 112.1</span> Visual comparison of systems used to quantify pelvic organ prolapse (POP). <span class="italic">AUGS</span>, American Urogynecologic Society; <span class="italic">ICS</span>, International Continence Society; SGS, Society of Gynecologic Surgeons. <br />
<span class="figcredit">From Theofrastous JP, Swift SE: The clinical evaluation of pelvic floor dysfunction. <span class="italic">Obstet Gynecol Clin North Am</span> 25:783–804, 1998.</span>
<span epub:type="pagebreak" title="435" id="pagebreak_435"></span>
</figcaption>
</figure>
</div>
</li>
<li id="sf0016">
<div class="pageavoid">
<figure class="fig" id="f0017">
<img src="../../IMAGES/B9780323639699001129/main.assets/f112-02-9780323639699.jpg" alt="image" class="box_img" />
<figcaption class="figleg">
<a id="cap9911"></a>
<a id="sp8865"></a>
<span class="fignum">Fig. 112.2</span> (A) Landmarks for the POP-Q system. (B) POP-Q points of reference. A, From Bump RC, Mattiasson A, Bo K, et al: The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. <span class="italic">Am J Obstet Gynecol</span> 175:10–17, 1996.</figcaption>
</figure>
</div>
</li>
<li class="b1numlista" id="bpar0130">
<a id="o0650"></a>24. Multichannel UDS offers extensive evaluation of LUT function. It involves direct measurement of bladder and intra-abdominal pressure (Pves and Pabd, respectively) and a calculated assessment of detrusor pressure that is independent of abdominal pressure (Pdet). Pves-Pabd=Pdet.</li>
<li class="b1numlista" id="bpar0135">
<a id="o0655"></a>25. Fluoroscopic imaging provides useful adjunctive information, such as the position and status of the bladder base and bladder neck, the presence of vesicoureteral reflux, and direct visualization of urinary leakage under real-time circumstances. Video imaging should be considered when the diagnosis cannot be made with certainty without simultaneous understanding of the anatomy in conjunction with the functional findings.</li>
</ul>
</div>
</div>
</section><span id="s0010"></span><span id="s0015"></span>
</body>
</html>
